Since the three time points chosen correspond to pre-plaque deposition, early plaque deposition and an advanced stage AD-like amyloid phenotype [3], we can conclude that neither age nor amyloid pathology alters SMIT1 or SMIT2 expression. The gene discussed is SLC5A3; the disease is Alzheimer disease.